Hydroeyes HS Eye Drop contains Ciclosporin 0.1% w/v, an immunomodulatory agent indicated for the treatment of dry eye disease associated with ocular inflammation. Ciclosporin acts by inhibiting T-lymphocyte activation, thereby reducing inflammation and promoting tear production in patients with keratoconjunctivitis sicca. Hydroeyes HS is formulated to improve tear film stability and alleviate symptoms such as ocular dryness, irritation, and burning sensation. It is intended for topical ophthalmic use and should be administered as directed by a healthcare professional, typically one drop in the affected eye(s) twice daily. The medication is contraindicated in patients with hypersensitivity to Ciclosporin or any component of the formulation. Common adverse effects may include transient ocular burning or stinging upon instillation, conjunctival hyperemia, and blurred vision. Patients should be advised to avoid contamination of the dropper tip and to discontinue use if signs of ocular infection or hypersensitivity occur. Hydroeyes HS Eye Drop is a valuable therapeutic option for managing chronic dry eye conditions by targeting the underlying inflammatory processes, thereby improving patient comfort and ocular surface health. Regular ophthalmologic monitoring is recommended during treatment to assess efficacy and safety.